{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:57:07Z","timestamp":1777931827035,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-023-02608-3","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T17:02:36Z","timestamp":1680886956000},"page":"2233-2259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Implementation of the vitiligo area scoring index in clinical studies of patients with vitiligo: a scoping review"],"prefix":"10.1007","volume":"315","author":[{"given":"Marissa S.","family":"Ceresnie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Warbasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aunna","family":"Pourang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iltefat H.","family":"Hamzavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,7]]},"reference":[{"issue":"6","key":"2608_CR1","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/jocd.13193","volume":"19","author":"NE Abd-Elazim","year":"2020","unstructured":"Abd-Elazim NE, Yassa HA, Mahran AM (2020) Microdermabrasion and topical tacrolimus: a novel combination therapy of vitiligo. J Cosmet Dermatol 19(6):1447\u20131455. https:\/\/doi.org\/10.1111\/jocd.13193","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"2608_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1365-2230.2006.02148.x","volume":"31","author":"MB Abdel-Naser","year":"2006","unstructured":"Abdel-Naser MB, El-Khateeb EA, Sallam TH, Habib MA (2006) Endothelin-1 is significantly elevated in plasma of patients with vitiligo treated with psoralen plus ultraviolet a. Clin Exp Dermatol 31(4):571\u2013575. https:\/\/doi.org\/10.1111\/j.1365-2230.2006.02148.x","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"2608_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4103\/JEWD.JEWD_41_19","volume":"17","author":"O Abu Zeid","year":"2020","unstructured":"Abu Zeid O, Omar N, El Sharkawy D (2020) The efficacy of combining fractional co2 laser and tacrolimus ointment in the treatment of vitiligo. J Egypt Women\u2019s Dermatol Soc 17(1):25\u201330. https:\/\/doi.org\/10.4103\/JEWD.JEWD_41_19","journal-title":"J Egypt Women's Dermatol Soc"},{"key":"2608_CR4","unstructured":"Abu-Raghif AR, Ali NM, Farhood IG, Hameed MF, Sahib HB (2013) Evaluation of a standardized extract of ginkgo biloba in vitiligo remedy. Asian journal of pharmaceutical and clinical research 6(SUPPL.5):127\u2010130. https:\/\/www.cochranelibrary.com\/central\/doi\/10.1002\/central\/CN-00910867\/full"},{"issue":"6","key":"2608_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13117","volume":"32","author":"TS Anbar","year":"2019","unstructured":"Anbar TS, Mohammed SS, Mohamed DM, Abdel-Rahman AT (2019) Clinical evaluation of interrupted versus continuous narrowband ultraviolet b phototherapy in nonsegmental vitiligo treatment: a prospective randomized comparative study. Dermatol Ther 32(6):e13117. https:\/\/doi.org\/10.1111\/dth.13117","journal-title":"Dermatol Ther"},{"key":"2608_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/01.EWX.0000473579.35791.9a","volume":"13","author":"S Awad","year":"2016","unstructured":"Awad S, Morsy H, Abdel-Aal A, Ibrahim A (2016) Effect of narrowband ultraviolet b phototherapy on serum vitamin d levels in patients with vitiligo. J Egypt Women\u02bcs Dermatol Soc 13:37\u201342. https:\/\/doi.org\/10.1097\/01.EWX.0000473579.35791.9a","journal-title":"J Egypt Women\u02bcs Dermatol Soc"},{"key":"2608_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.06.880","author":"JM Bae","year":"2021","unstructured":"Bae JM, Zubair R, Ju HJ et al (2021) Development and validation of the fingertip unit for assessing facial vitiligo area scoring index (f-vasi). J Am Acad Dermatol. https:\/\/doi.org\/10.1016\/j.jaad.2021.06.880","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2608_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/phpp.12072","volume":"29","author":"S Bansal","year":"2013","unstructured":"Bansal S, Sahoo B, Garg V (2013) Psoralen-narrowband uvb phototherapy for the treatment of vitiligo in comparison to narrowband uvb alone. Photodermatol Photoimmunol Photomed 29(6):311\u2013317. https:\/\/doi.org\/10.1111\/phpp.12072","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2608_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-020-02108-8","author":"A Bishnoi","year":"2020","unstructured":"Bishnoi A, Vinay K, Kumaran MS, Parsad D (2020) Oral mycophenolate mofetil as a stabilizing treatment for progressive non-segmental vitiligo: results from a prospective, randomized, investigator-blinded pilot study. Arch Dermatol Res. https:\/\/doi.org\/10.1007\/s00403-020-02108-8","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"2608_CR10","first-page":"273","volume":"17","author":"V Cervelli","year":"2009","unstructured":"Cervelli V, De Angelis B, Balzani A, Colicchia G, Spallone D, Grimaldi M (2009) Treatment of stable vitiligo by recell system. Acta Dermatovenerol Croat 17(4):273\u2013278","journal-title":"Acta Dermatovenerol Croat"},{"issue":"2","key":"2608_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1600-0781.2011.00643.x","volume":"28","author":"BM El-Zawahry","year":"2012","unstructured":"El-Zawahry BM, Bassiouny DA, Sobhi RM et al (2012) A comparative study on efficacy of uva1 vs. Narrow-band uvb phototherapy in the treatment of vitiligo. Photodermatol Photoimmunol Photomed 28(2):84\u201390. https:\/\/doi.org\/10.1111\/j.1600-0781.2011.00643.x","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"4","key":"2608_CR12","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/jocd.12808","volume":"18","author":"BM El-Zawahry","year":"2019","unstructured":"El-Zawahry BM, Elmasry MF, Ragab A (2019) The role of long-wavelength ultraviolet al (uva1) in acral vitiligo. J Cosmet Dermatol 18(4):1155\u20131160. https:\/\/doi.org\/10.1111\/jocd.12808","journal-title":"J Cosmet Dermatol"},{"issue":"9","key":"2608_CR13","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/s10103-017-2290-y","volume":"32","author":"MB El-Zawahry","year":"2017","unstructured":"El-Zawahry MB, Zaki NS, Wissa MY, Saleh MA (2017) Effect of combination of fractional co(2) laser and narrow-band ultraviolet b versus narrow-band ultraviolet b in the treatment of non-segmental vitiligo. Lasers Med Sci 32(9):1953\u20131958. https:\/\/doi.org\/10.1007\/s10103-017-2290-y","journal-title":"Lasers Med Sci"},{"key":"2608_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.14235\/bs.2016.1007","volume":"5","author":"N Emiroglu","year":"2018","unstructured":"Emiroglu N, Cengiz F, Bahali A, B\u0131y\u0131k Ozkaya D, Su O, Onsun N (2018) Effectiveness of the capparis spinosa treatment in vitiligo. Bezmialem Sci 5:145\u2013149. https:\/\/doi.org\/10.14235\/bs.2016.1007","journal-title":"Bezmialem Sci"},{"issue":"2","key":"2608_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4103\/jewd.Jewd_4_19","volume":"16","author":"A Farag","year":"2019","unstructured":"Farag A, Hammam M, Al-Sharaky D, Hassan R, ElShafey E, Ali N (2019) Role of chemokine ligand 22 in narrow-band ultraviolet b-induced pigmentation in vitiligo: an immunohistochemical study. J Egypt Women\u00eds Dermatol Soc 16(2):97\u2013104. https:\/\/doi.org\/10.4103\/jewd.Jewd_4_19","journal-title":"J Egypt Women\u00eds Dermatol Soc"},{"issue":"4","key":"2608_CR16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1590\/abd1806-4841.20198250","volume":"94","author":"AGA Farag","year":"2019","unstructured":"Farag AGA, Hammam MA, Al-Sharaky DR, El-Boghdady GM (2019) Leucine-rich glioma inactivated 3: a novel keratinocyte-derived melanogenic cytokine in vitiligo patients. An Bras Dermatol 94(4):434\u2013441. https:\/\/doi.org\/10.1590\/abd1806-4841.20198250","journal-title":"An Bras Dermatol"},{"issue":"6","key":"2608_CR17","doi-asserted-by":"publisher","first-page":"e4515","DOI":"10.5812\/ircmj.4515","volume":"16","author":"A Ghorbanibirgani","year":"2014","unstructured":"Ghorbanibirgani A, Khalili A, Rokhafrooz D (2014) Comparing nigella sativa oil and fish oil in treatment of vitiligo. Iran Red Crescent Med J 16(6):e4515. https:\/\/doi.org\/10.5812\/ircmj.4515","journal-title":"Iran Red Crescent Med J"},{"issue":"6","key":"2608_CR18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/archderm.140.6.677","volume":"140","author":"I Hamzavi","year":"2004","unstructured":"Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H (2004) Parametric modeling of narrowband uv-b phototherapy for vitiligo using a novel quantitative tool: the vitiligo area scoring index. Arch Dermatol 140(6):677\u2013683. https:\/\/doi.org\/10.1001\/archderm.140.6.677","journal-title":"Arch Dermatol"},{"issue":"2","key":"2608_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5826\/dpc.0702a06","volume":"7","author":"F Handjani","year":"2017","unstructured":"Handjani F, Aghaei S, Moezzi I, Saki N (2017) Topical mycophenolate mofetil in the treatment of vitiligo: a pilot study. Dermatol Pract Concept 7(2):31\u201333. https:\/\/doi.org\/10.5826\/dpc.0702a06","journal-title":"Dermatol Pract Concept"},{"issue":"4","key":"2608_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/exd.12369","volume":"23","author":"RA Hegazy","year":"2014","unstructured":"Hegazy RA, Fawzy MM, Gawdat HI, Samir N, Rashed LA (2014) T helper 17 and tregs: a novel proposed mechanism for nb-uvb in vitiligo. Exp Dermatol 23(4):283\u2013286. https:\/\/doi.org\/10.1111\/exd.12369","journal-title":"Exp Dermatol"},{"issue":"5","key":"2608_CR21","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jaad.2011.05.002","volume":"66","author":"RH Huggins","year":"2012","unstructured":"Huggins RH, Henderson MD, Mulekar SV et al (2012) Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the united states. J Am Acad Dermatol 66(5):785\u2013793. https:\/\/doi.org\/10.1016\/j.jaad.2011.05.002","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2608_CR22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/jocd.12515","volume":"17","author":"H Ibrahim","year":"2018","unstructured":"Ibrahim H, El Taieb M, El Gamel Z, El Saied AR (2018) Effect of narrow-band ultraviolet b on the serum of 25-hydroxyvitamin d in vitiligo patients. J Cosmet Dermatol 17(5):911\u2013916. https:\/\/doi.org\/10.1111\/jocd.12515","journal-title":"J Cosmet Dermatol"},{"key":"2608_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/2277-9175.203159","volume":"6","author":"F Iraji","year":"2017","unstructured":"Iraji F, Banihashemi SH, Faghihi G, Shahmoradi Z, Tajmirriahi N, Jazi SB (2017) A comparison of betamethasone valerate 0.1% cream twice daily plus oral simvastatin versus betamethasone valerate 0.1% cream alone in the treatment of vitiligo patients. Adv Biomed Res 6:34. https:\/\/doi.org\/10.4103\/2277-9175.203159","journal-title":"Adv Biomed Res"},{"key":"2608_CR24","doi-asserted-by":"publisher","first-page":"472546","DOI":"10.1155\/2014\/472546","volume":"2014","author":"A Kalafi","year":"2014","unstructured":"Kalafi A, Jowkar F (2014) Evaluation of the efficacy of topical tetracycline in enhancing the effect of narrow band uvb against vitiligo: a double-blind, randomized, placebo-controlled clinical trial. ISRN Dermatol 2014:472546. https:\/\/doi.org\/10.1155\/2014\/472546","journal-title":"ISRN Dermatol"},{"issue":"8","key":"2608_CR25","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.jid.2019.11.031","volume":"140","author":"A Khemis","year":"2020","unstructured":"Khemis A, Fontas E, Moulin S, Montaudi\u00e9 H, Lacour JP, Passeron T (2020) Apremilast in combination with narrowband uvb in the treatment of vitiligo: A 52-week monocentric prospective randomized placebo-controlled study. J Invest Dermatol 140(8):1533-1537.e1532. https:\/\/doi.org\/10.1016\/j.jid.2019.11.031","journal-title":"J Invest Dermatol"},{"issue":"7","key":"2608_CR26","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s13555-022-00752-8","volume":"12","author":"H Kitchen","year":"2022","unstructured":"Kitchen H, Wyrwich KW, Carmichael C et al (2022) Meaningful changes in what matters to individuals with vitiligo: content validity and meaningful change thresholds of the vitiligo area scoring index (vasi). Dermatol Ther (Heidelb) 12(7):1623\u20131637. https:\/\/doi.org\/10.1007\/s13555-022-00752-8","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"2608_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/bjd.13432","volume":"172","author":"L Komen","year":"2015","unstructured":"Komen L, da Gra\u00e7a V, Wolkerstorfer A, de Rie MA, Terwee CB, van der Veen JP (2015) Vitiligo area scoring index and vitiligo european task force assessment: reliable and responsive instruments to measure the degree of depigmentation in vitiligo. Br J Dermatol 172(2):437\u2013443. https:\/\/doi.org\/10.1111\/bjd.13432","journal-title":"Br J Dermatol"},{"issue":"1","key":"2608_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1001\/jamadermatol.2014.1875","volume":"151","author":"HW Lim","year":"2015","unstructured":"Lim HW, Grimes PE, Agbai O et al (2015) Afamelanotide and narrowband uv-b phototherapy for the treatment of vitiligo: a randomized multicenter trial. JAMA Dermatol 151(1):42\u201350. https:\/\/doi.org\/10.1001\/jamadermatol.2014.1875","journal-title":"JAMA Dermatol"},{"issue":"1","key":"2608_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/phpp.12495","volume":"36","author":"B Liu","year":"2020","unstructured":"Liu B, Sun Y, Song J, Wu Z (2020) Home vs hospital narrowband uvb treatment by a hand-held unit for new-onset vitiligo: a pilot randomized controlled study. Photodermatol Photoimmunol Photomed 36(1):14\u201320. https:\/\/doi.org\/10.1111\/phpp.12495","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"3","key":"2608_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4103\/0378-6323.62964","volume":"76","author":"I Majid","year":"2010","unstructured":"Majid I (2010) Topical placental extract: does it increase the efficacy of narrowband uvb therapy in vitiligo? Indian J Dermatol Venereol Leprol 76(3):254\u2013258. https:\/\/doi.org\/10.4103\/0378-6323.62964","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5","key":"2608_CR31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1600-0781.2010.00540.x","volume":"26","author":"I Majid","year":"2010","unstructured":"Majid I (2010) Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet b therapy in vitiligo? A left-right comparison study. Photodermatol Photoimmunol Photomed 26(5):230\u2013234. https:\/\/doi.org\/10.1111\/j.1600-0781.2010.00540.x","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"3","key":"2608_CR32","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/bjd.21246","volume":"187","author":"R Merhi","year":"2022","unstructured":"Merhi R, Canu D, Barnetche T et al (2022) Assessment of vitiligo area scoring index (vasi), facial-vasi and vitiligo extent score using standardized photography of patients with vitiligo. Br J Dermatol 187(3):422\u2013424. https:\/\/doi.org\/10.1111\/bjd.21246","journal-title":"Br J Dermatol"},{"key":"2608_CR33","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20165354","author":"KH Mou","year":"2016","unstructured":"Mou KH, Han D, Liu WL, Li P (2016) Combination therapy of orally administered glycyrrhizin and uvb improved active-stage generalized vitiligo. Braz J Med Biol Res. https:\/\/doi.org\/10.1590\/1414-431x20165354","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"2608_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00403-017-1792-6","volume":"310","author":"HR Nada","year":"2018","unstructured":"Nada HR, El Sharkawy DA, Elmasry MF, Rashed LA, Mamdouh S (2018) Expression of janus kinase 1 in vitiligo & psoriasis before and after narrow band uvb: a case-control study. Arch Dermatol Res 310(1):39\u201346. https:\/\/doi.org\/10.1007\/s00403-017-1792-6","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"2608_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22034\/ijd.2019.98364","volume":"22","author":"Y Nahidi","year":"2019","unstructured":"Nahidi Y, Pouran L, Tayyebi Meibodi N, Vakili V, Kardan G (2019) Serum level of vitamin d3 in vitiligo patients before and after treatment with narrow band uvb. Is there an association with treatment? Iran J Dermatol 22(1):1\u20136. https:\/\/doi.org\/10.22034\/ijd.2019.98364","journal-title":"Iran J Dermatol"},{"key":"2608_CR36","unstructured":"Namazi MR, Shotorbani AK (2015) Evaluation of the efficacy of topical ethyl vanillate in enhancing the effect of narrow band ultraviolet b against vitiligo: a double blind randomized, placebo-controlled clinical trial. Iran J Med Sci 40(6):478\u2013484. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4628137\/pdf\/IJMS-40-478.pdf"},{"issue":"6","key":"2608_CR37","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1001\/jamadermatol.2017.6401","volume":"154","author":"S Nguyen","year":"2018","unstructured":"Nguyen S, Chuah SY, Fontas E et al (2018) Atorvastatin in combination with narrowband uv-b in adult patients with active vitiligo: a randomized clinical trial. JAMA Dermatol 154(6):725\u2013726. https:\/\/doi.org\/10.1001\/jamadermatol.2017.6401","journal-title":"JAMA Dermatol"},{"issue":"2","key":"2608_CR38","doi-asserted-by":"publisher","first-page":"e65045","DOI":"10.5812\/jjnpp.65045","volume":"13","author":"M Omidian","year":"2018","unstructured":"Omidian M, Asadian T (2018) Evaluation of serum vitamin d levels in patients with vitiligo undergoing nbuvb (narrowband uv-b) therapy. Jundishapur J Nat Pharm Prod 13(2):e65045. https:\/\/doi.org\/10.5812\/jjnpp.65045","journal-title":"Jundishapur J Nat Pharm Prod"},{"issue":"3","key":"2608_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00580-018-2651-3","volume":"27","author":"M Omidian","year":"2018","unstructured":"Omidian M, Pazyar N, Zahra-al Sadat M (2018) Is vitamin d supplement accompanied with narrow band uvb effective for treatment of vitiligo? Comp Clin Pathol 27(3):685\u2013690. https:\/\/doi.org\/10.1007\/s00580-018-2651-3","journal-title":"Comp Clin Pathol"},{"key":"2608_CR40","doi-asserted-by":"publisher","first-page":"868","DOI":"10.7897\/2277-4343.03640","volume":"3","author":"H Panigrahi","year":"2012","unstructured":"Panigrahi H, Rana R, Rao MM (2012) Efficacy of leech therapy and ayurvedic compound in vitiligo: a quasi experimental study. Int J Res Ayur Pharm 3:868\u2013871. https:\/\/doi.org\/10.7897\/2277-4343.03640","journal-title":"Int J Res Ayur Pharm"},{"key":"2608_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.colsurfb.2014.02.005","volume":"119","author":"HK Patel","year":"2014","unstructured":"Patel HK, Barot BS, Parejiya PB, Shelat PK, Shukla A (2014) Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo\u2013part ii: rheological characterization and in vivo assessment through dermatopharmacokinetic and pilot clinical studies. Colloids Surf B Biointerfaces 119:145\u2013153. https:\/\/doi.org\/10.1016\/j.colsurfb.2014.02.005","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"2608_CR42","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1111\/ajd.13008","volume":"60","author":"ML Peralta-Pedrero","year":"2019","unstructured":"Peralta-Pedrero ML, Morales-S\u00e1nchez MA, Jurado-Santa Cruz F, De la Torre-Garc\u00eda ME, Cruz-Peralta ES, Olgu\u00edn-Garc\u00eda MG (2019) Systematic review of clinimetric instruments to determine the severity of non-segmental vitiligo. Australas J Dermatol 60(3):e178\u2013e185. https:\/\/doi.org\/10.1111\/ajd.13008","journal-title":"Australas J Dermatol"},{"key":"2608_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12619","author":"P Poolsuwan","year":"2020","unstructured":"Poolsuwan P, Churee C, Pattamadilok B (2020) Comparative efficacy between localized 308-nm excimer light and targeted 311-nm narrowband ultraviolet b phototherapy in vitiligo: a randomized, single-blind comparison study. Photodermatol Photoimmunol Photomed. https:\/\/doi.org\/10.1111\/phpp.12619","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"10244","key":"2608_CR44","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/s0140-6736(20)30609-7","volume":"396","author":"D Rosmarin","year":"2020","unstructured":"Rosmarin D, Pandya AG, Lebwohl M et al (2020) Ruxolitinib cream for treatment of vitiligo: A randomised, controlled, phase 2 trial. Lancet 396(10244):110\u2013120. https:\/\/doi.org\/10.1016\/s0140-6736(20)30609-7","journal-title":"Lancet"},{"issue":"6","key":"2608_CR45","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jaad.2017.02.049","volume":"76","author":"B Rothstein","year":"2017","unstructured":"Rothstein B, Joshipura D, Saraiya A et al (2017) Treatment of vitiligo with the topical janus kinase inhibitor ruxolitinib. J Am Acad Dermatol 76(6):1054-1060.e1051. https:\/\/doi.org\/10.1016\/j.jaad.2017.02.049","journal-title":"J Am Acad Dermatol"},{"key":"2608_CR46","doi-asserted-by":"publisher","first-page":"493213","DOI":"10.1155\/2014\/493213","volume":"2014","author":"M Sehrawat","year":"2014","unstructured":"Sehrawat M, Arora TC, Chauhan A, Kar HK, Poonia A, Jairath V (2014) Correlation of vitamin d levels with pigmentation in vitiligo patients treated with nbuvb therapy. ISRN Dermatol 2014:493213. https:\/\/doi.org\/10.1155\/2014\/493213","journal-title":"ISRN Dermatol"},{"issue":"4","key":"2608_CR47","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/bjd.14204","volume":"174","author":"N Silpa-Archa","year":"2016","unstructured":"Silpa-Archa N, Griffith JL, Williams MS, Lim HW, Hamzavi IH (2016) Prospective comparison of recipient-site preparation with fractional carbon dioxide laser vs. dermabrasion and recipient-site dressing composition in melanocyte-keratinocyte transplantation procedure in vitiligo: a preliminary study. Br J Dermatol 174(4):895\u2013897. https:\/\/doi.org\/10.1111\/bjd.14204","journal-title":"Br J Dermatol"},{"issue":"2","key":"2608_CR48","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jaad.2017.01.056","volume":"77","author":"N Silpa-Archa","year":"2017","unstructured":"Silpa-Archa N, Griffith JL, Huggins RH et al (2017) Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas. J Am Acad Dermatol 77(2):318\u2013327. https:\/\/doi.org\/10.1016\/j.jaad.2017.01.056","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"2608_CR49","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1080\/09546634.2018.1544409","volume":"30","author":"N Silpa-Archa","year":"2019","unstructured":"Silpa-Archa N, Weerasubpong P, Junsuwan N, Yothachai P, Supapueng O, Wongpraparut C (2019) Treatment outcome and persistence of repigmentation from narrow-band ultraviolet b phototherapy in vitiligo. J Dermatolog Treat 30(7):691\u2013696. https:\/\/doi.org\/10.1080\/09546634.2018.1544409","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"2608_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/0378-6323.125479","volume":"80","author":"A Singh","year":"2014","unstructured":"Singh A, Kanwar AJ, Parsad D, Mahajan R (2014) Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris. Indian J Dermatol Venereol Leprol 80(1):29\u201335. https:\/\/doi.org\/10.4103\/0378-6323.125479","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2608_CR51","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1472-6882-11-21","volume":"11","author":"O Szczurko","year":"2011","unstructured":"Szczurko O, Shear N, Taddio A, Boon H (2011) Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial. BMC Complement Altern Med 11:21. https:\/\/doi.org\/10.1186\/1472-6882-11-21","journal-title":"BMC Complement Altern Med"},{"issue":"5","key":"2608_CR52","doi-asserted-by":"publisher","first-page":"528","DOI":"10.4103\/ijdvl.IJDVL_656_18","volume":"85","author":"A Taneja","year":"2019","unstructured":"Taneja A, Kumari A, Vyas K, Khare AK, Gupta LK, Mittal AK (2019) Cyclosporine in treatment of progressive vitiligo: an open-label, single-arm interventional study. Indian J Dermatol Venereol Leprol 85(5):528\u2013531. https:\/\/doi.org\/10.4103\/ijdvl.IJDVL_656_18","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"2608_CR53","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/jocd.12759","volume":"18","author":"YM Tawfik","year":"2019","unstructured":"Tawfik YM, Abd Elazim NE, Abdel-Motaleb AA, Mohammed RAA, Tohamy AMA (2019) The effect of nb-uvb on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios. J Cosmet Dermatol 18(2):638\u2013646. https:\/\/doi.org\/10.1111\/jocd.12759","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"2608_CR54","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3889\/oamjms.2019.068","volume":"7","author":"HDT Thu","year":"2019","unstructured":"Thu HDT, Hong NDT, Van TN et al (2019) The decline of puva therapy in vietnam: effective treatment of narrow band uvb in vietnamese vitiligo patients. Open Access Maced J Med Sci 7(2):256\u2013258. https:\/\/doi.org\/10.3889\/oamjms.2019.068","journal-title":"Open Access Maced J Med Sci"},{"issue":"1","key":"2608_CR55","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jaad.2016.06.015","volume":"76","author":"SG Vanderweil","year":"2017","unstructured":"Vanderweil SG, Amano S, Ko WC et al (2017) A double-blind, placebo-controlled, phase-ii clinical trial to evaluate oral simvastatin as a treatment for vitiligo. J Am Acad Dermatol 76(1):150-151.e153. https:\/\/doi.org\/10.1016\/j.jaad.2016.06.015","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"2608_CR56","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.5958\/0974-360X.2019.01029.1","volume":"12","author":"RAHA Vinodini","year":"2019","unstructured":"Vinodini RAHA, Meenakshi Sundaram M, Muthukumar NJ (2019) Clinical evaluation of parangipattai chooranam (internal) and annabedhi chenduram (external) for venpulli (vitiligo) in children. Res J Pharm Technol 12(12):5932\u20135936. https:\/\/doi.org\/10.5958\/0974-360X.2019.01029.1","journal-title":"Res J Pharm Technol"},{"issue":"8","key":"2608_CR57","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/ced.13290","volume":"42","author":"M Vu","year":"2017","unstructured":"Vu M, Heyes C, Robertson SJ, Varigos GA, Ross G (2017) Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo. Clin Exp Dermatol 42(8):942\u2013944. https:\/\/doi.org\/10.1111\/ced.13290","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"2608_CR58","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1111\/ajd.13184","volume":"61","author":"N Zabolinejad","year":"2020","unstructured":"Zabolinejad N, Maleki M, Salehi M, Ashrafi Z, Molkara S, Layegh P (2020) Psoralen and narrowband uvb combination provides higher efficacy in treating vitiligo compared with narrowband uvb alone: a randomised clinical trial. Australas J Dermatol 61(1):e65\u2013e69. https:\/\/doi.org\/10.1111\/ajd.13184","journal-title":"Australas J Dermatol"},{"issue":"1","key":"2608_CR59","first-page":"30","volume":"27","author":"M Zahoor","year":"2017","unstructured":"Zahoor M, Shaukat S, Khan MS, Ahmad TJ (2017) Comparison of efficacy and safety of 0.005% calcipotriol ointment versus 0.05% betamethasone dipropionate ointment versus calcipotriol plus betamethasone ointment for the treatment of vitiligo. J Pak Assoc Dermatol 27(1):30\u201336","journal-title":"J Pak Assoc Dermatol"},{"issue":"4","key":"2608_CR60","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/phpp.12462","volume":"35","author":"L Zhang","year":"2019","unstructured":"Zhang L, Wang X, Chen S et al (2019) Comparison of efficacy and safety profile for home nb-uvb vs. Outpatient nb-uvb in the treatment of non-segmental vitiligo: a prospective cohort study. Photodermatol Photoimmunol Photomed 35(4):261\u2013267. https:\/\/doi.org\/10.1111\/phpp.12462","journal-title":"Photodermatol Photoimmunol Photomed"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02608-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-023-02608-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02608-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T06:04:32Z","timestamp":1693202672000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-023-02608-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,7]]},"references-count":60,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["2608"],"URL":"https:\/\/doi.org\/10.1007\/s00403-023-02608-3","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,7]]},"assertion":[{"value":"3 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MSC is a sub-investigator for Avita Medical, Incyte Corporation, Clinuvel Pharmaceuticals, and the Immune Tolerance Network. IHH helped develop the vitiligo area scoring index and has served as an advisory board member for AbbVie; a consultant for Incyte Corporation, Pfizer, and UCB; a principal investigator for AbbVie, Allergan, Avita Medical, Bayer, Clinuvel Pharmaceuticals, Est\u00e9e Lauder, Ferndale Laboratories, Galderma Laboratories LP, GE Healthcare, Incyte Corporation, Janssen, Janssen Biotech, Johnson & Johnson, Lenicura, LEO Pharma, Pfizer, The Immune Tolerance Network, and Unigen; a sub-investigator for Amgen, Bristol Myers Squibb, Foamix Pharmaceuticals, and Janssen; past-president of the Hidradenitis Suppurativa Foundation; and co-chair of the Global Vitiligo Foundation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a scoping review and does not include information or images which could identify or potentially identify individuals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}